Printer Friendly

Immunetrics Receives $100,000 STTR Grant.

PITTSBURGH -- Immunetrics Inc., a Pittsburgh-based biomedical startup venture, said it received a $100,000 grant from the National Institutes of Health to support development of its software model of inflammation in sepsis.

Working with researchers at the University of Pittsburgh, Immunetrics is commercializing software tools to aid in the diagnosis and treatment of sepsis, a complex syndrome resulting from runaway inflammatory response. Immunetrics expects the technology not only to support diagnosis but also to aid in the development of effective therapeutics, a significant challenge for the pharmaceutical industry.

The grant is partly intended to assist Immunetrics in optimizing the mathematical model to promote the understanding of anthrax infection, which creates sepsis-like symptoms.

"Sepsis and anthrax poisoning share features related to the significant complexity of inflammatory response," said Yoram Vodovotz, Ph.D., a University of Pittsburgh immunologist serving as principal investigator in the STTR grant. "This funding will help deepen our understanding of the consequences of anthrax infection while aiding Immunetrics in the development of clinically useful tools to address runaway inflammatory response in various shock states."

Immunetrics was established by LaunchCyte LLC of Pittsburgh, a for-profit incubator that creates, seeds, and harvests life science innovation. CEO Steven Chang is a successful technology entrepreneur with more than a decade of experience in developing complex computer models, optimization algorithms, and data mining systems.

MAKE YOUR OPINION COUNT - Click Here http://tbutton.prnewswire.com/prn/11690X14318711

Contact: Tom Petzinger of LaunchCyte LLC, +1-412-697-2900, or tom@launchcyte.com

Website: http://www.launchcyte.com/
COPYRIGHT 2002 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 25, 2002
Words:249
Previous Article:BrokerTec Continues Growth and Profitability Trend During 2nd Quarter.
Next Article:PT International Nickel Indonesia Tbk reports second quarter 2002 earnings of $11.2 million (U.S.) reflecting stronger nickel prices.


Related Articles
SBA Announces States Eligible for $1 Million Fund to Boost Small Business R&D.
Statewide Conference Featuring Federal Programs Offering $1.6 Billion In Funding for Innovative Research & Development Solutions Slated For September...
Immunetrics, Inc. Receives $100,000 Investment; Pittsburgh Life Sciences Greenhouse Provides Pre-Seed Investment in Early Stage Company through its...
Immunetrics Technology Accelerates Development of University of Pittsburgh Animal Model.
DOE Small Business grants.
EndGenitor Technologies Expands Its Board of Directors with Guido J. Neels and is Awarded Two Grants.
NASA Selects 287 Small Business Research and Tech Projects.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters